Emeryville, CA, United States of America

Hamiduddin Khoja

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hamiduddin Khoja. Retrieved from https://idiyas.com/inventor/hamiduddin-khoja

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hamiduddin Khoja: Innovator in Cancer Research

Introduction

Hamiduddin Khoja is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on the development of diagnostic and therapeutic methods for cancer treatment.

Latest Patents

Khoja holds a patent for the invention titled "HX2004-6 polypeptide expressed in cancerous cells." This invention provides polynucleotides and polypeptides that are differentially expressed in cancer cells. These polynucleotides are instrumental in various diagnostic and therapeutic methods. Furthermore, the invention outlines methods for reducing the growth of cancer cells, which are essential for treating cancer.

Career Highlights

Khoja is currently associated with Novartis Vaccines & Diagnostics GmbH, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on improving cancer therapies.

Collaborations

Some of his notable coworkers include Christoph Reinhard and Anne B Jefferson, who have collaborated with him on various projects within the field of cancer research.

Conclusion

Hamiduddin Khoja's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving therapeutic methods for cancer treatment. His work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…